Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 70Squamous Cell Carcinoma of Head and Neck 32Parkinson Disease 4, Autosomal Dominant Lewy Body 30Lung Neoplasms 28Melanoma 24Triple Negative Breast Neoplasms 23Neoplasms 20Neoplasm Metastasis 20Breast Neoplasms 19Colorectal Neoplasms 18Head and Neck Neoplasms 15Endometrial Neoplasms 15Ovarian Neoplasms 14Carcinoma, Renal Cell 13Urinary Bladder Neoplasms 11Carcinoma, Transitional Cell 10Pancreatic Neoplasms 7Hodgkin Disease 7Esophageal Neoplasms 7Uterine Cervical Neoplasms 6Sarcoma 6Recurrence 6Lymphoma 6Carcinoma 6Stomach Neoplasms 4Small Cell Lung Carcinoma 4Prostatic Neoplasms 4Multiple Myeloma 4Mouth Neoplasms 4Lymphoma, Large B-Cell, Diffuse 4

Interventions

pembrolizumab 1Pemetrexed 1Paclitaxel 1Oxaliplatin 1Leucovorin 1Gemcitabine 1Fluorouracil 1Cisplatin 1Cetuximab 1Carboplatin 1Bevacizumab 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Pancreatic Ductal × pembrolizumab × 30 days × Clear all
NCT06704724 2026-05-22

A Study to Learn About the Study Medicine PF-07985045 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Change in a Gene.

Pfizer

Phase 1 Terminated
30 enrolled
GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Lung Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Carcinoma, Pancreatic Ductal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡